Study Details

Back to Search Results

A study of ASP2074 in adults with solid tumors

This trial is recruiting
The study is currently recruiting participants.

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT05646797

Astellas Study ID

The unique identification code given by the study sponsor.

2074-CL-0101

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Advanced/Metastatic Cancer

Phase

These clinical trials are usually the first time an experimental treatment is studied in a small group of people.

Phase 1

Age

18 Years - N/A

Sex

Female & Male

Product

ASP2074

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Feb 2023 - Dec 2027

Masking

None (Open Label)

Enrollment number

193

A Phase 1/1b Study of ASP2074 in Participants with Metastatic or Locally Advanced Solid Tumors

Study summary

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A study of ASP2074 in adults with solid tumors? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

National Cancer Center Hospital East

Kashiwa, Japan

Recruiting
Contact Us

Virginia Mason Medical Center

Seattle, United States, 98101

Recruiting
Contact Us

South Texas Oncology & Hematology

San Antonio, United States, 78253

Recruiting
Contact Us

National Cancer Center Hospital

Chuo-ku, Japan

Recruiting
Contact Us

Karmanos Cancer Institute

Detroit, United States, 48201

Recruiting
Contact Us

Aichi Cancer Center

Nagoya, Japan

Recruiting
Contact Us

The Cancer Institute Hospital of Japanese Foundation for Cancer Research

Koto-ku, Japan

Recruiting
Contact Us

University of Iowa Hospitals

Iowa City, United States, 52242

Recruiting
Contact Us

Osaka International Cancer Institute

Osaka, Japan

Recruiting
Contact Us

University of California Davis Health System

Sacramento, United States, 95817

Recruiting
Contact Us

START Midwest

Grand Rapids, United States, 49546

Recruiting
Contact Us

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo